NORTH ATTLEBORO, Mass., July 20, 2011 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a leading regulatory consulting firm and CRO for the medical device industry, announced today that Mr. Frederick (Fred) Tobia has joined the company as director of regulatory and clinical services. He will oversee the daily operations of the company's clinical and regulatory services groups, reporting to Vicki Anastasi, vice president of regulatory services and business development.

Fred brings over twenty years of experience in the medical device and CRO industry and has held increasingly senior executive roles in regulatory, quality and clinical affairs at Alliant Medical Technologies, Inc. (formerly UroMed), CareStat Inc., and Seacoast Technologies. For the past six years he was vice president, regulatory and clinical affairs at NMT Medical Inc. He has successfully gained clearance and approval of PMAs, 510(k)s, IDEs, INDs, NDAs, BLAs, and international Design Dossiers with and without clinical data. 

"I am excited to welcome Fred to MDCI," said Anastasi. "His impressive track record of integrating worldwide regulatory, clinical and quality programs, along with a proven ability to manage the device development process from pre-clinical through post-market activities will serve our clients well."

Fred holds a bachelor of science in biology from Providence College and a certificate in public health from Harvard School of Public Health.  He has published numerous articles in peer-reviewed journals and is a recognized speaker and advisor with medical device industry trade and professional organizations, including FDA task forces.

About MDCI

Founded in 1980, MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deli